{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T05:56:20Z","timestamp":1776318980023,"version":"3.50.1"},"reference-count":22,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007771","name":"Medical University of Silesia in Katowice","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007771","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>PCOS is a common endocrine disorder that impacts hormonal, metabolic, and reproductive health. Its prevalence is steadily increasing, including in the pediatric population, yet there is still a lack of research thoroughly examining the problem of teenage PCOS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>The purpose of the study was to determine the prevalence and clinical-hormonal profile of PCOS among teenage patients with hyperandrogenism and\/or menstrual disorders, depending on the adopted diagnostic criteria.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>An observational study was conducted on a group of 289 patients referred for diagnosis due to hyperandrogenism and\/or menstrual disorders in the years 2019-2022. The study participant were assigned to appropriate groups depending on the diagnostic criteria met (patients with PCOS according to Ibanez, Pe\u00f1a, Rotterdam and patients without PCOS) and descriptive statistics and correlation studies were prepared.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The prevalence of polycystic ovary syndrome ranged from approximately 46% to 59%, depending on the diagnostic criteria applied. No statistically significant differences in clinical or hormonal parameters were observed between the three PCOS diagnostic groups (Ib\u00e1\u00f1ez, Pe\u00f1a, and Rotterdam). However, patients meeting any PCOS definition differed significantly from those meeting no diagnostic criteria (NO PCOS group) in selected hormonal parameters: LH (p&amp;lt;0.001), total testosterone (p&amp;lt;0.001), androstenedione (p=0.003), and ovarian volume, consistent with established PCOS pathophysiology. The most frequent menstrual abnormality was \u201coligomenorrhea &amp;gt;45 days\u201d. Clinical hyperandrogenism was more common than biochemical hyperandrogenism (88.1%\u201391.5% vs. 54.9%\u201355.3%), indicating that clinical signs of androgen excess predominate in adolescents. Acne occurred in around 70% of girls with polycystic ovary syndrome and in less than 40% of those without it. Across all diagnostic definitions, ovarian volume was consistently higher in patients diagnosed with the syndrome, even in cases not meeting the traditional criteria for polycystic ovarian morphology.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The high prevalence of polycystic ovary syndrome among adolescents underscores the need for standardized diagnostic approaches. Improved understanding of clinical and hormonal profiles in this population can\u00a0facilitate earlier and more accurate diagnosis, enabling timely preventive and\u00a0therapeutic interventions to reduce long-term metabolic and reproductive complications.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1785417","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T05:26:15Z","timestamp":1776317175000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Prevalence of polycystic ovary syndrome among adolescents depending on the adopted diagnostic criteria"],"prefix":"10.3389","volume":"17","author":[{"given":"Karolina","family":"Jakubowska-Kowal","sequence":"first","affiliation":[{"name":"Department of Pediatrics and Pediatric Endocrinology, Medical University of Silesia","place":["Katowice, Poland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karolina","family":"Skrzy\u0144ska","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Pediatric Endocrinology, Medical University of Silesia","place":["Katowice, Poland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karolina","family":"Kowalczyk","sequence":"additional","affiliation":[{"name":"Department of Gynecology, Obstetrics and Gynecological Oncology, Medical University of Silesia","place":["Katowice, Poland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aneta","family":"Gawlik-Starzyk","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Pediatric Endocrinology, Medical University of Silesia","place":["Katowice, Poland"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-024-07607-x","article-title":"Global prevalence of polycystic ovary syndrome in women worldwide: a comprehensive systematic review and meta-analysis","volume":"310","author":"Salari","year":"2024","journal-title":"Arch Gynecol Obstet"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.18502\/ijrm.v17i8.4818","article-title":"The prevalence of polycystic ovary syndrome in adolescents: a systematic review and meta-analysis","volume":"17","author":"Naz","year":"2019","journal-title":"Int J Reprod BioMed"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dead156","article-title":"Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"38","author":"Teede","year":"2023","journal-title":"Hum Reprod"},{"key":"B4","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12916-020-01516-x","article-title":"Adolescent polycystic ovary syndrome according to the international evidence-based guideline","volume":"18","author":"Pe\u00f1a","year":"2020","journal-title":"BMC Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1111\/ijpo.12586","article-title":"Polycystic ovary syndrome in adolescent girls","volume":"15","author":"Ib\u00e1\u00f1ez","year":"2020","journal-title":"Pediatr Obes"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgae518","article-title":"Rising incidence, health resource utilization, and costs of polycystic ovary syndrome in the United Kingdom","volume":"110","author":"Berni","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjco.2023.12.010","article-title":"Increased prevalence of adverse health outcomes across the lifespan in those affected by polycystic ovary syndrome: a Canadian population cohort","volume":"6","author":"Vine","year":"2024","journal-title":"CJC Open"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(81)90746-8","article-title":"Hirsutism: implications, etiology, and management","volume":"140","author":"Hatch","year":"1981","journal-title":"Am J Obstet Gynecol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1093\/ejendo\/lvae125","article-title":"Prevalence and accurate diagnosis of polycystic ovary syndrome in adolescents across world regions: a systematic review and meta-analysis","volume":"191","author":"Neven","year":"2024","journal-title":"Eur J Endocrinol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.jpag.2025.06.008","article-title":"Incidence and prevalence of polycystic ovary syndrome in adolescent and young adult US military dependents from 2018 to 2022","volume":"38","author":"Parker","year":"2025","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"74","DOI":"10.21037\/apm-20-1893","article-title":"The prevalence of polycystic ovarian syndrome in Chinese women: a meta-analysis","volume":"10","author":"Wu","year":"2021","journal-title":"Ann Palliat Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"39.e1","DOI":"10.1016\/j.ajog.2023.04.010","article-title":"Incidence, prevalence, and trends in polycystic ovary syndrome diagnosis: a United States population-based study from 2006 to 2019","volume":"229","author":"Yu","year":"2023","journal-title":"Am J Obstet Gynecol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph21030354","article-title":"Prevalence and diagnosis of PCOS using electronic health records: a scoping review and a database analysis","volume":"21","author":"Atiomo","year":"2024","journal-title":"Int J Environ Res Public Health"},{"key":"B14","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1530\/endoabs.35.P813","article-title":"Polycystic ovary syndrome in overweight and obese adolescent girls and its association with insulin resistance and metabolic syndrome","volume":"35","author":"Smetanina","year":"2014","journal-title":"Endocrine Abstracts"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.47454","article-title":"Prevalence of polycystic ovary syndrome in patients with pediatric type 2 diabetes: a systematic review and meta-analysis","volume":"5","author":"Cioana","year":"2022","journal-title":"JAMA Netw Open"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1159\/000471805","article-title":"High prevalence of polycystic ovary syndrome in type 1 diabetes mellitus adolescents: is there a difference depending on the NIH and Rotterdam criteria","volume":"87","author":"Busiah","year":"2017","journal-title":"Horm Res Paediatr"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1569694","article-title":"Evolving global trends in PCOS burden: a three-decade analysis (1990\u20132021) with projections to 2036 among adolescents and young adults","volume":"16","author":"Wang","year":"2025","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.2174\/1381612822666160720151243","article-title":"Hirsutism in polycystic ovary syndrome: pathophysiology and management","volume":"22","author":"Spritzer","year":"2016","journal-title":"Curr Pharm Des"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpag.2012.05.002","article-title":"Ferriman-Gallwey scores, serum androgen and Mullerian inhibiting substance levels in hirstute adolescent girls","volume":"25","author":"Hertweck","year":"2012","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1080\/09513590.2020.1859474","article-title":"Prevalence of acne vulgaris among women with polycystic ovary syndrome: a systemic review and meta-analysis","volume":"37","author":"Ramezani Tehrani","year":"2021","journal-title":"Gynecol Endocrinol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2015.03.026","article-title":"Ovarian volume in normal and hyperandrogenic adolescent women","volume":"104","author":"Fruzzetti","year":"2015","journal-title":"Fertil Steril"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmad027","article-title":"Ultrasonographic criteria in the diagnosis of polycystic ovary syndrome: a systematic review and diagnostic meta-analysis","volume":"30","author":"Pea","year":"2024","journal-title":"Hum Reprod Update"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1785417\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T05:26:16Z","timestamp":1776317176000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1785417\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,16]]},"references-count":22,"alternative-id":["10.3389\/fendo.2026.1785417"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1785417","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,16]]},"article-number":"1785417"}}